Bio Path Stock Price

-0.15 (-4.41%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Bio Path Holdings Inc BPTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.15 -4.41% 3.25 19:47:57
Close Price Low Price High Price Open Price Previous Close
3.28 3.18 3.48 3.45 3.40
Bid Price Ask Price Spread News
3.25 3.28 0.03 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,188 308,487 $ 3.26 $ 1,005,012 1,834,513 2.9203 - 15.7432
Last Trade Time Type Quantity Stock Price Currency
19:56:09 1 $ 3.28 USD

Bio Path Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.00M 3.69M 3.66M $ - $ - -3.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Bio Path News

Date Time Source News Article
10/22/202016:31Edgar (US Regulatory)Current Report Filing (8-k)
10/22/202007:00GlobeNewswire Inc.Bio-Path Receives Notice of Allowance for Strategic Patent..
9/10/202016:17Edgar (US Regulatory)Current Report Filing (8-k)
9/09/202008:00GlobeNewswire Inc.Bio-Path Holdings to Present at the H.C. Wainwright 22nd..
8/14/202007:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2020 Financial..
8/13/202016:31Edgar (US Regulatory)Current Report Filing (8-k)
8/13/202016:12Edgar (US Regulatory)Quarterly Report (10-q)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BPTH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.944.943.184.07869,434-1.69-34.21%
1 Month4.,691,184-0.94-22.43%
3 Months5.,060,503-1.77-35.26%
6 Months5.306.973.185.14529,779-2.05-38.68%
1 Year11.5515.74322.92035.46329,708-8.30-71.86%
3 Years80.0084.001.6018.73612,045-76.75-95.94%
5 Years319.98638.001.6055.31465,383-316.73-98.98%

Bio Path Description

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.
Your Recent History
Bio Path
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201031 17:37:31